Emergent BioSolutions Inc. (NYSE:EBS) Receives $28.00 Consensus PT from Analysts
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received an average recommendation of “Hold” from the five research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the […]